But it wasn't quite that simple. The scientists had to employ a trick - in the reactor, neutron irradiation splits boron atoms into very light and fast ions of helium and lithium. The nanocrystals must first be dispersed in molten boron oxide and then subjected to neutron irradiation in a nuclear reactor. Neutron capture by boron nuclei produces a dense shower of helium and lithium ions, which have the same effect within the nanocrystals as the ions produced in an accelerator: the controlled creation of crystal defects. The high density of this particle shower and the use of a reactor to irradiate a much larger quantity of material mean that it is easier and far more affordable to produce dozens of grams of rare nanomaterial at once, which is approximately one thousand times more than scientists have thus far been able to obtain through comparable irradiation in accelerators.
The method has proven successful not only in the creation of defects in the lattice of nanodiamonds but of another nanomaterial as well - silicon carbide. For this reason, scientists hypothesize that the method could find universal application in the large-scale production of nanoparticles with defined defects.

Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The new method utilizes the principle applied in boron neutron capture therapy (BNCT), in which patients are administered a boron compound. Once the compound has collected in the tumor, the patient receives radiation therapy with neutrons, which split the boron nuclei into ions of helium and lithium. These then destroy the tumor cells that the boron has collected in. This principle taken from experimental cancer treatment thus has opened the door to the efficient production of nanomaterials with exceptional potential for applications in, among other areas, cancer diagnostics.
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences / IOCB Prague is a leading internationally recognized scientific institution whose primary mission is the pursuit of basic research in chemical biology and medicinal chemistry, organic and materials chemistry, chemistry of natural substances, biochemistry and molecular biology, physical chemistry, theoretical chemistry, and analytical chemistry. An integral part of the IOCB Prague's mission is the implementation of the results of basic research in practice. Emphasis on interdisciplinary research gives rise to a wide range of applications in medicine, pharmacy, and other fields.
Back to HCB News